Clinical remission with biologic therapies in severe asthma: a matter of definition
| dc.contributor.author | UK Severe Asthma Registry | |
| dc.date.accessioned | 2024-07-15T10:54:19Z | |
| dc.date.available | 2024-07-15T10:54:19Z | |
| dc.date.issued | 2024-06-20 | |
| dc.identifier.citation | UK Severe Asthma Registry; McDowell PJ, McDowell R, Busby J, Eastwood MC, Patel PH, Jackson DJ, Mansur A, Patel M, Burhan H, Doe S, Chaudhuri R, Gore R, Dodd JW, Subramanian D, Brown T, Heaney LG. Clinical remission with biologic therapies in severe asthma: a matter of definition. Eur Respir J. 2024 Jun 20;63(6):2400160. doi: 10.1183/13993003.00160-2024. PMID: 38901893; PMCID: PMC11187314. | en_US |
| dc.identifier.uri | http://hdl.handle.net/20.500.14200/5129 | |
| dc.description.abstract | There is currently no evidence to support the use of maintenance and reliever therapy (MART) in patients with severe asthma and persistently elevated T2 biomarkers despite adherence to high dose ICS treatment https://bit.ly/42IOVbA | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | European Respiratory Society | en_US |
| dc.subject | Respiratory medicine | en_US |
| dc.title | Clinical remission with biologic therapies in severe asthma: a matter of definition | en_US |
| dc.type | Article | en_US |
| dc.source.journaltitle | The European Respiratory Journal | en_US |
| rioxxterms.version | NA | en_US |
| dc.contributor.trustauthor | Mansur, Adel | |
| dc.contributor.department | Consultant Thoracic Medicine | en_US |
| dc.contributor.role | Medical and Dental | en_US |
| oa.grant.openaccess | na | en_US |